2021 Form 10-K Financial Statement

#000156459022006822 Filed on February 25, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $155.0K $2.056M
YoY Change -92.46%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.428M $4.026M
YoY Change -14.86%
Operating Profit -$3.191M -$1.444M
YoY Change 120.91% -128.16%
Interest Expense $2.264K $6.190K
YoY Change -63.42%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $22.81M -$54.33M
YoY Change -141.99% -503.37%
Net Earnings / Revenue 14721.54% -2641.82%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $366.4M
YoY Change 52.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $209.8K
YoY Change -98.17%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $366.2M
YoY Change
Total Liabilities & Shareholders Equity $366.4M
YoY Change 52.79%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income $22.81M -$54.33M
YoY Change -141.99% -503.37%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$328.3M -$192.2M
YoY Change 70.84% -165.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$328.3M -$181.7M
YoY Change 80.72% -163.88%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 328.3M 181.7M
YoY Change 80.72% -162.77%
NET CHANGE
Cash From Operating Activities -328.3M -192.2M
Cash From Investing Activities
Cash From Financing Activities 328.3M 181.7M
Net Change In Cash 0.000 -10.51M
YoY Change -100.0% -281.14%
FREE CASH FLOW
Cash From Operating Activities -$328.3M -$192.2M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
998130
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
376104
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
204951
CY2021Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
4032
CY2020Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
4859
CY2021Q4 us-gaap Liabilities
Liabilities
3164491
CY2020Q4 us-gaap Liabilities
Liabilities
209810
CY2021Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
1025
CY2020Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
970
CY2021Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
717344145
CY2020Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
366184845
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
717345170
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
366185815
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
720509661
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
366395625
CY2021Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2020Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2021Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
28000000
CY2020Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
15100000
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.62
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
24.25
CY2021Q4 uup Market Value Per Share
MarketValuePerShare
25.63
CY2020Q4 uup Market Value Per Share
MarketValuePerShare
24.26
CY2021Q4 uup Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
626489060
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
718493794
CY2021Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
27997200
CY2020Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
365396641
CY2020Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
365396641
CY2020Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.9978
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
365394178
CY2021 us-gaap Interest Expense
InterestExpense
2264
CY2020 us-gaap Operating Expenses
OperatingExpenses
4026087
CY2019 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
102795
CY2020 uup Realized Gain Loss On Affiliated Investments
RealizedGainLossOnAffiliatedInvestments
9822
CY2021 uup Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
8454
CY2020 uup Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
20471
CY2019 uup Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
11446
CY2021 uup Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
26417232
CY2020 uup Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
-50897716
CY2019 uup Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
5422705
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
718465017
CY2020 uup Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
-2073161
CY2021 uup Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
-396346
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22812199
CY2019 us-gaap Net Income Loss
NetIncomeLoss
13468833
CY2020 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
668542085
CY2019 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
915211456
CY2021 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
289000000
CY2019 uup Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
2719194
CY2021 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-422660
CY2020 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-2011748
CY2019 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
2844263
CY2021 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
26003026
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
366185815
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
755794494
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
427447338
CY2021 uup Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
328347156
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-3190827
CY2021 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
26425686
CY2021 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
351159355
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1444371
CY2020 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-50872611
CY2020 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-2011748
CY2020 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
137868598
CY2019 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5050773
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
5128644
CY2019 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
5495926
CY2019 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
2844263
CY2019 us-gaap Net Income Loss
NetIncomeLoss
13468833
CY2019 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-266035375
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
228317217
CY2020 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
672934371
CY2019 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1206589525
CY2021 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1000484866
CY2020 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
2307497397
CY2019 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
766376656
CY2021 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
619414864
CY2020 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
2167831112
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
717345170
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1863160467
CY2020 uup Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
192197328
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-54328730
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
228317217
CY2020 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1670963139
CY2021Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0016
CY2019 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
763039150
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-79890
CY2020 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-777478
CY2021Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2020 uup Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
4634
CY2019 uup Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
61775
CY2021 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-26314
CY2020 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
61413
CY2019 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
125069
CY2021 uup Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-3782485
CY2021 uup Decrease Increase In Due From Broker
DecreaseIncreaseInDueFromBroker
-2034654
CY2021 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
6673
CY2020 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-25102
CY2019 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-30303
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
171153
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
51169
CY2019 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-170581
CY2021 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-827
CY2020 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
858
CY2019 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-653
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-328347156
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-192196828
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
295268749
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
5050773
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
755794494
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1863160467
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
201428538
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
427447338
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1681468713
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
485847145
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
328347156
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
181691754
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-289469380
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10505074
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5799369
CY2020Q4 us-gaap Cash
Cash
0
CY2019Q4 us-gaap Cash
Cash
10505074
CY2020 us-gaap Interest Paid Net
InterestPaidNet
6190
CY2019 us-gaap Interest Paid Net
InterestPaidNet
10911
CY2021 uup Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
CY2021 uup Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2021 uup Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:3.33%;text-indent:-3.33%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">B.  Accounting Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</p>
CY2021 us-gaap Distributed Earnings
DistributedEarnings
0
CY2020 us-gaap Distributed Earnings
DistributedEarnings
0
CY2021 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
82133
CY2021 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
0
CY2021 us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5 - Deposits with Commodity Broker and Custodian</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund defines cash as cash held by the Custodian. There were no cash equivalents held by the Fund as of December 31, 2021 and 2020. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker. The Fund may deposit T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the currency futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption <span style="font-style:italic;">Due to custodian</span>.</p>
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
92006259
CY2021Q4 uup Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
49855000
CY2021Q4 uup Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
576603758
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
718465017
CY2021Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
-4284830
CY2021Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
714180187
CY2020Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
119984182
CY2020Q4 uup Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
49876240
CY2020Q4 uup Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
195533756
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
365394178
CY2020Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
-3888484
CY2020Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
361505694
CY2021 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
8454
CY2020 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
20471
CY2019 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
11446
CY2021 uup Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2021 uup Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2021 uup Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
CY2021 uup Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.95
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-1.63
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.61
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.07
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.39
CY2020 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.70
CY2019 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.00
CY2019 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.53
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0384
CY2019 uup Return At Market Value
ReturnAtMarketValue
0.0405

Files In Submission

Name View Source Status
0001564590-22-006822-index-headers.html Edgar Link pending
0001564590-22-006822-index.html Edgar Link pending
0001564590-22-006822.txt Edgar Link pending
0001564590-22-006822-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gwbav1ayuf02000001.jpg Edgar Link pending
gwbav1ayuf02000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uup-10k_20211231.htm Edgar Link pending
uup-10k_20211231_htm.xml Edgar Link completed
uup-20211231.xsd Edgar Link pending
uup-20211231_cal.xml Edgar Link unprocessable
uup-20211231_def.xml Edgar Link unprocessable
uup-20211231_lab.xml Edgar Link unprocessable
uup-20211231_pre.xml Edgar Link unprocessable
uup-ex231_7.htm Edgar Link pending
uup-ex311_12.htm Edgar Link pending
uup-ex312_11.htm Edgar Link pending
uup-ex313_8.htm Edgar Link pending
uup-ex314_10.htm Edgar Link pending
uup-ex321_6.htm Edgar Link pending
uup-ex322_14.htm Edgar Link pending
uup-ex323_9.htm Edgar Link pending
uup-ex324_13.htm Edgar Link pending